Since there are many pharmacological agents available that target purinergic receptors in a specific manner, in vivo studies aimed at understanding the impact of purinergic receptor signaling in viral encephalitis have the potential to deliver  treatments for better outcomes of encephalitis. The gene discussed is P2RX1; the disease is encephalitis.